178 related articles for article (PubMed ID: 30365075)
21. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death.
Silva-Carvalho AÉ; Alencar APD; Resende MR; da Costa DF; Nonino A; Neves FAR; Saldanha-Araujo F
Toxicol In Vitro; 2020 Dec; 69():104992. PubMed ID: 32889036
[TBL] [Abstract][Full Text] [Related]
22. G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma.
Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
Neuromolecular Med; 2022 Dec; 24(4):392-398. PubMed ID: 35113321
[TBL] [Abstract][Full Text] [Related]
23. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
[No Abstract] [Full Text] [Related]
24. Expression and prognostic significance of chromatin modulators EHMT2/G9a and KDM2b in acute myeloid leukemia.
Gouda MBY; Zidane MA; Abdelhady AS; Hassan NM
J Cell Biochem; 2022 Aug; 123(8):1340-1355. PubMed ID: 35696556
[TBL] [Abstract][Full Text] [Related]
25. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
[TBL] [Abstract][Full Text] [Related]
26. EHMT2/G9a Inhibits Aortic Smooth Muscle Cell Death by Suppressing Autophagy Activation.
Chen TQ; Hu N; Huo B; Masau JF; Yi X; Zhong XX; Chen YJ; Guo X; Zhu XH; Wei X; Jiang DS
Int J Biol Sci; 2020; 16(7):1252-1263. PubMed ID: 32174799
[TBL] [Abstract][Full Text] [Related]
27. Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.
Nguyen K; Das B; Dobrowolski C; Karn J
mBio; 2017 Feb; 8(1):. PubMed ID: 28246360
[TBL] [Abstract][Full Text] [Related]
28. The Expression of HSPD1, SCUBE3, CXCL14 and Its Relations with the Prognosis in Osteosarcoma.
Liang W; Yang C; Peng J; Qian Y; Wang Z
Cell Biochem Biophys; 2015 Dec; 73(3):763-8. PubMed ID: 27259322
[TBL] [Abstract][Full Text] [Related]
29. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.
Zhang X; Peng D; Xi Y; Yuan C; Sagum CA; Klein BJ; Tanaka K; Wen H; Kutateladze TG; Li W; Bedford MT; Shi X
Nat Commun; 2016 Mar; 7():10810. PubMed ID: 26960573
[TBL] [Abstract][Full Text] [Related]
30. Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2.
Leenders R; Zijlmans R; van Bree B; van de Sande M; Trivarelli F; Damen E; Wegert A; Müller D; Ehlert JE; Feger D; Heidemann-Dinger C; Kubbutat M; Schächtele C; Lenstra DC; Mecinović J; Müller G
Bioorg Med Chem Lett; 2019 Sep; 29(17):2516-2524. PubMed ID: 31350126
[TBL] [Abstract][Full Text] [Related]
31. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
[TBL] [Abstract][Full Text] [Related]
32. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
[TBL] [Abstract][Full Text] [Related]
34. E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases.
Karthik IP; Desai P; Sukumar S; Dimitrijevic A; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Apr; 293(15):5624-5635. PubMed ID: 29467226
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemistry for histone h3 lysine 9 methyltransferase and demethylase proteins in human melanomas.
Miura S; Maesawa C; Shibazaki M; Yasuhira S; Kasai S; Tsunoda K; Maeda F; Takahashi K; Akasaka T; Masuda T
Am J Dermatopathol; 2014 Mar; 36(3):211-6. PubMed ID: 24658378
[TBL] [Abstract][Full Text] [Related]
36. Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.
Parma B; Ramesh V; Gollavilli PN; Siddiqui A; Pinna L; Schwab A; Marschall S; Zhang S; Pilarsky C; Napoli F; Volante M; Urbanczyk S; Mielenz D; Schrøder HD; Stemmler M; Wurdak H; Ceppi P
J Exp Clin Cancer Res; 2021 Aug; 40(1):248. PubMed ID: 34364401
[TBL] [Abstract][Full Text] [Related]
37. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300
[TBL] [Abstract][Full Text] [Related]
38. MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites.
Watanabe S; Iimori M; Chan DV; Hara E; Kitao H; Maehara Y
Sci Rep; 2018 Jul; 8(1):10888. PubMed ID: 30022091
[TBL] [Abstract][Full Text] [Related]
39. EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS
Pribluda A; Daemen A; Lima AN; Wang X; Hafner M; Poon C; Modrusan Z; Katakam AK; Foreman O; Eastham J; Hung J; Haley B; Garcia JT; Jackson EL; Junttila MR
Elife; 2022 Aug; 11():. PubMed ID: 35983994
[TBL] [Abstract][Full Text] [Related]
40. Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability.
Lee JY; Lee SH; Heo SH; Kim KS; Kim C; Kim DK; Ko JJ; Park KS
PLoS One; 2015; 10(10):e0141118. PubMed ID: 26492085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
